Business Description
InfuSystems Holdings Inc
NAICS : 339112
SIC : 3841
Description
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | 0.49 | |||||
Debt-to-Equity | 0.73 | |||||
Debt-to-EBITDA | 2.45 | |||||
Interest Coverage | 1.97 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.16 | |||||
Beneish M-Score | -2.81 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 9 | |||||
3-Year EBITDA Growth Rate | -10.1 | |||||
3-Year EPS without NRI Growth Rate | -63.2 | |||||
3-Year FCF Growth Rate | -68.2 | |||||
3-Year Book Growth Rate | 7.1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 123.27 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 8.34 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 26.12 | |||||
9-Day RSI | 35.31 | |||||
14-Day RSI | 39.04 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.07 | |||||
Quick Ratio | 1.64 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 35.08 | |||||
Days Sales Outstanding | 56.44 | |||||
Days Payable | 45.81 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.5 | |||||
Shareholder Yield % | 3.03 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 49.68 | |||||
Operating Margin % | 3.06 | |||||
Net Margin % | 0.28 | |||||
FCF Margin % | -1.04 | |||||
ROE % | 0.71 | |||||
ROA % | 0.35 | |||||
ROIC % | 0.81 | |||||
3-Year ROIIC % | -163.36 | |||||
ROC (Joel Greenblatt) % | 6.35 | |||||
ROCE % | 4.34 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 473.08 | |||||
Forward PE Ratio | 55.77 | |||||
PE Ratio without NRI | 473.08 | |||||
Shiller PE Ratio | 295.2 | |||||
PEG Ratio | 147.84 | |||||
PS Ratio | 1.03 | |||||
PB Ratio | 2.45 | |||||
Price-to-Tangible-Book | 3.07 | |||||
Price-to-Operating-Cash-Flow | 11.52 | |||||
EV-to-EBIT | 44.03 | |||||
EV-to-EBITDA | 10.63 | |||||
EV-to-Revenue | 1.31 | |||||
EV-to-FCF | -127.32 | |||||
Price-to-Projected-FCF | 4.22 | |||||
Price-to-Median-PS-Value | 0.76 | |||||
Price-to-Peter-Lynch-Fair-Value | 90 | |||||
Price-to-Graham-Number | 7.94 | |||||
Earnings Yield (Greenblatt) % | 2.27 | |||||
FCF Yield % | -1.02 | |||||
Forward Rate of Return (Yacktman) % | 4.73 |